Response

Chest

Volumn 139, Issue 1, 2011, Pages 233-234

  Imberti, Roberto ^a   Iotti, Giorgio A ^a   Cusato, Maria ^a   Regazzi, Mario ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIMETHATE;

AEROSOL; CHROMATOGRAPHY; DISEASE SEVERITY; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG PENETRATION; HUMAN; LETTER; LUNG PARENCHYMA; NONHUMAN; PHYSICAL CHEMISTRY; PNEUMONIA; PRIORITY JOURNAL;

EID: 78651418559     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2107     Document Type: Letter

References (7)

1. Li J, Nation RL, Turnidge JD, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006;6(9):589-601.
2. Ziv G, Nouws JFM, van Ginneken CAM. The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves. J Vet Pharmacol Ther. 1982;5(1):45-58.
3. Kunin CM, Bugg A. Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body. J Infect Dis. 1971;124(4):394-400.
4. Lu Q, Girardi C, Zhang M, et al. Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa. Intensive Care Med. 2010;36(7):1147-1155.
5. Jin L, Li J, Nation RL, Nicolazzo JA. Brain penetration of colistin in mice assessed by a novel high-performance liquid chromatographic technique. Antimicrob Agents Chemother. 2009;53(10):4247-4251.
6. Imberti R, Cusato M, Villani P, et al. Steady-state pharmacokinetics and BAL concentration of colistin in critically ill patients after IV colistin methanesulfonate administration. Chest. 2010;138(6):1333-1339.
7. Aoki N, Tateda K, Kikuchi Y, et al. Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. J Antimicrob Chemother. 2009;63(3):534-542.